Tackling Persistent Pediatric Cancer Drug Scarcity

Cancer drug shortages continue to disrupt care for children, underscoring vulnerabilities in the pharmaceutical supply chain. Economic pressures on drug manufacturers highlight the need for more effective policies and collaboration among healthcare providers, pharmaceutical companies, and policymakers.